Benzinga | May 6, 2021 04:43PM EDT

NovaBay Pharmaceuticals Q1 EPS $(0.04), Inline, Sales $1.80M Miss $2.34M Estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $1.80 million which missed the analyst consensus estimate of $2.34 million by 23.08 percent. This is a 4.86 percent decrease over sales of $1.89 million the same period last year.